{"id":"W1979457312","doi":"10.1016/j.ddstr.2013.11.001","title":"Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure","year":2012,"lang":"en","type":"review","venue":"Drug Discovery Today Therapeutic Strategies","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates; Heart and Stroke Foundation of Canada","keywords":"Angiotensin-converting enzyme 2; Heart failure; Angiotensin II; Angiotensin II receptor type 1; Pressure overload; Internal medicine; Receptor; Endocrinology; Renin–angiotensin system; Ventricular remodeling; Medicine; Muscle hypertrophy; Angiotensin-converting enzyme; Myocardial infarction; Angiotensin 1; Fibrosis; Blood pressure; Pharmacology; Cardiac hypertrophy; Disease","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001005189,0.001908519,0.006432063,0.0008457658,0.0002678195,0.0005303121,0.0004034999,0.0007267777,0.00005488965],"category_scores_gemma":[0.00005011347,0.001306464,0.001384934,0.001362993,0.0004439251,0.001172369,0.0002267879,0.001413726,0.0001223066],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004058707,"about_ca_system_score_gemma":0.001078128,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003991837,"about_ca_topic_score_gemma":0.0002818702,"domain_scores_codex":[0.9929695,0.0007892731,0.001997387,0.001430956,0.001073013,0.001739937],"domain_scores_gemma":[0.9962448,0.0006724602,0.001059167,0.001457681,0.0002909666,0.0002749529],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002573498,0.003502857,0.03180809,0.06792472,0.04812223,0.00489598,0.02948713,0.000659332,0.002038425,0.02559334,0.02120114,0.7621933],"study_design_scores_gemma":[0.001868956,0.000171175,0.004738888,0.03742642,0.008338658,0.002020347,0.003747672,0.00004190949,0.000108783,0.0001051135,0.9391419,0.002290237],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001901481,0.9923165,0.00008305282,0.001058235,0.0007521973,0.002679372,0.00004654815,0.0002784479,0.0008841279],"genre_scores_gemma":[0.1588095,0.8331568,0.002239889,0.0006283729,0.002135117,0.0002658903,0.0003329964,0.0007173789,0.001714142],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9179407,"threshold_uncertainty_score":0.9993659,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05245593690220392,"score_gpt":0.3157799530829468,"score_spread":0.2633240161807429,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}